Syphilitic polyradiculopathy in an HIV-positive man

Neurology

Volumn 38, Issue 8, 1988, Pages 1297-1301

  Lanska, Mary Jo ^a   Lanska, Douglas J ^a   Schmidley, James W ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; ELECTROMYOGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRALYMPHATIC DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; POLYRADICULITIS; PRIORITY JOURNAL; SYPHILIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CASE REPORT; HUMAN; MALE; PENICILLINS; PERIPHERAL NERVOUS SYSTEM DISEASES; SYPHILIS;

EID: 0023802481     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.8.1297     Document Type: Article

References (40)

1. Vendrell J, Heredia C, Pujol M, et al. Guillain-Barre syndrome associated with seroconversion for anti-HTLV-III. Neurology 1987;37:544.
2. Przedborski S, Liesnard C, Hildebrand J. HTLV-III and vacuolar myelopathy. N Engl J Med 1986;315:63.
3. Eidelberg D, Sotrel A, Vogel H, et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986;36:912–916.
4. Behar R, Wiley C, McCutchan A. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology 1987;37:557–561.
5. Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987;21:32–40.
6. Berger JR, Difini JA, Swerdloff MA, Ayyar DR. HIV seropositivity in Cuillain-BarrC syndrome. Ann Neurol 1987;22:393–394.
7. Asbury AK. Diagnostic considerations in Guillain-Barre syndrome. Ann Neurol 1981;9(suppl):1–5.
8. Adams RD, Memtt HH. Meningeal and vascular syphilis of the spinal cord. Medicine 1944;23:181–214.
9. Memtt HH, Adams RD, Solomon HC. Neurosyphilis. New York Oxford University Preee, 1946:146.
10. Burke JM, Schaberg DR. Neurosyphilis in the antibiotic era. Neurology 1985;35:1368–1371.
11. Martin JP. Amyotrophic meningo-myelitis (spinal progressive muscular atrophy of syphilitic origin). Brain 1925;48:153–182.
12. Simon RP. Nemyphilis. Arch Neurol 1985;42:606–613.
13. Merritt HH, Moore M. Acute syphilitic meningitis. Medicine 1935;14:119–183.
14. Ayer JB, Solomon HC. Cerebrospinal fluid from difflerent loci. Arch Neurol Psychiat 1925;14:303–314.
15. Moas AR, Osmond D, Bacchetti P, et al. Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol 1987;125:1035–1047.
16. Sindrup JH, Weismann K, Wantzin GL. Syphilis in HTLV-III infected male homosexuals. AIDS Res 1986;2:285–288.
17. Tate L, Wright R, Schmid H, et al. Tertiary syphilis deaths-South Florida. MMWR 1987;36:488–491.
18. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987;316:1569–1572.
19. Berry CD, Hooton TM, Collier AC, Lukehart SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987;316:1587–1589.
20. Smolin C, Nozik RA, Okumoto M. Growth of Treponema pallidum in rabbits. Am J Ophthalmol 1970;70:273–276.
21. Musher DM, Schell RF. The immunology of syphilis. Hosp Pract 1975;December:45–50.
22. Turner DR, Wright DJM. Lymphadenopathy in early syphilis. J Pathol 1973;110:305–308.
23. Levene GM, Turk JL, Wright DJM, Grimble AGS. Reduced lymphocyte transformation due to a plasma factor in patienta with active syphilis. Lancet 1969;2:246–247.
24. Pavia CS, Folds JD, Baseman JB. Selective in vitro response of thymus-derived lymphocytes from Treponemu pallidum-infected rabbits. Infect Immun 1977;18:603–611.
25. Center for Disease Control. Recommended treatment schedules for syphilis 1976. MMWR 1976;25:101–107.
26. Center for Disease Control. 1985 STD treatment guidelines. MMWR 1985;34:948–998.
27. Moskovitz BL, Klimek JJ, Coldman RL, et al. Meningovascular Syphilis after “appropriate” treatment of primary syphilis. Arch Intern Med 1982;142:139–140.
28. Holmes MD, Brant-Zawadzki MM, Simon RP. Clinical features of meningovascular syphilis. Neurology 1984;34:553–556.
29. Saltiel P, Melmed CA, Portnoy D. Sensorineural deafness in early acquired syphilis. Can J Neur Sci 1983;10:114–116.
30. Hoffman BF. Neurosyphilis in a young man. Can J Psychiatry 1981;26:68–70.
31. Markovitz DM, Beutner KR, Maggio RP, Reichman RC. Failure of recommended treatment for secondary syphilis. JAMA 1986;255:1767–1768.
32. Jorgensen J, Tikjob G, Weismann K. Neurosyphilis after treatment of latent syphilis with benzathine penicillin. Genitourin Med 1986;62:129–131.
33. Bayne LL, Schmidley JW, Goodin DS. Acute syphilitic meningitis: its occurrence after clinical and serologic cure of secondary syphilis with penicillin G. Arch Newl 1986;43:137–138.
34. Fiumara NJ. Treatment of primary and secondary syphilis: serological response. JAMA 1980;243:2500–2502.
35. Brown ST, Zaidi A, Lareen SA, Reynolds GH. Serological response to syphilis treatment: a new analysis of old data. JAMA 1985;253:1296–1299.
36. Greene BM, Miller NR, Bynum TE. Failure of penicillin G benzathine in the treatment of neurosyphilis. Arch Intern Med 1980;140:1117–1118.
37. Tramont EC. Persistence of Treponema pallidum following penicillin G therapy: report of two caaes. JAMA 1976;236:2206–2207.
38. Yoder FW. Penicillin treatment of neurosyphilis. Are recommended dosages sufficient? JAMA 1975;232:270–271.
39. Mohr JA, Griffiths W, Jackson R, et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976;236:2208–2209.
40. Schoth PEM, Woltere EC. Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology 1987;37:1214–1216.